Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen *

• Company:

  AstraZeneca Pharmaceuticals (Ireland) DAC

• Status:

  No Recent Update

• Legal Category:

  Product subject to medical prescription which may not be renewed (A)

• Active Ingredient(s):

  Exenatide

  *Additional information is available within the SPC or upon request to the company